Xspray Pharma AB (publ) announced that the company is strengthening its organization by creating an Investor Relations and Communications function. Christina Malmberg H?gerstrand has been appointed Vice President and Head of Investor Relations and Communications, she joins Xspray Pharma in January 2022. With extensive experience in corporate communication, media relations and financial communication, Christina Malmberg H?gerstrand joins from her current role as Director of External Communication at AstraZeneca AB. She has previously held positions as Head of Communications at Nasdaq Nordic and Baltic and Head of External Communications at Alecta. Christina holds an LL.M. in Law from Stockholm University. She is also a trained journalist and has worked at Dagens Industri and news agency Infront Direkt. Christina will join Xspray Pharma on January 10, 2022 and will be part of the executive team.